Literature DB >> 33048872

Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.

Jinyu Zhang1,2, Bal Krishna Chand Thakuri1,2, Juan Zhao1,2, Lam N Nguyen1,2, Lam N T Nguyen1,2, Dechao Cao1,2, Xindi Dang1,2, Sushant Khanal1,2, Madison Schank1,2, Zeyuan Lu1,2, Xiao Y Wu1,2, Zheng D Morrison1,2, Mohamed El Gazzar1, Zhengke Li1, Yong Jiang1, Shunbin Ning1,2, Ling Wang1,2, Jonathan P Moorman1,2,3, Zhi Q Yao1,2,3.   

Abstract

OBJECTIVE: Myeloid-derived suppressor cells (MDSCs) contribute to HIV progression by impairing antiviral immunity; however, the mechanisms responsible for MDSC development during HIV infection are incompletely understood. HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) is a long noncoding RNA (lncRNA) that plays a pivotal role in regulating myeloid cell development via targeting HOXA1. The role of HOTAIRM1--HOXA1 in the differentiation and functions of MDSCs during HIV infection remains unclear.
METHODS: In this study, we measured MDSC induction and suppressive functions by flow cytometry, RT-PCR, and co-culture experiments using CD33 myeloid cells derived from people living with HIV (PLHIV) on antiretroviral therapy (ART). We also manipulated the HOTAIRM1--HOXA1 axis in myeloid cells using knockdown and overexpression approaches.
RESULTS: We demonstrate that HOTAIRM1 and HOXA1 expressions are reciprocally upregulated and are responsible for increased levels of immunosuppressive molecules, such as arginase 1 (Arg1), inducible nitric oxide synthase (iNOS), signal transducer and activator of transcription 3 (STAT3), and reactive oxygen species (ROS), in CD33 myeloid cells derived from PLHIV on ART. We found that overexpression of HOTAIRM1 or HOXA1 in CD33 cells isolated from healthy individuals promoted the differentiation and suppressive functions of MDSCs, whereas silencing of HOTAIRM1 or HOXA1 expression in MDSCs derived from PLHIV significantly inhibited the frequency of MDSCs and expressions of the immunosuppressive molecules and reduced their immunosuppressive effects on T cells.
CONCLUSION: These results indicate that the HOTAIRM1--HOXA1 axis enhances differentiation and suppressive functions of MDSCs and could be a potential therapeutic target for immunomodulation during latent HIV infection.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33048872      PMCID: PMC7674250          DOI: 10.1097/QAD.0000000000002700

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  50 in total

1.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Authors:  D Persaud; T Pierson; C Ruff; D Finzi; K R Chadwick; J B Margolick; A Ruff; N Hutton; S Ray; R F Siliciano
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.

Authors:  John L Rinn; Michael Kertesz; Jordon K Wang; Sharon L Squazzo; Xiao Xu; Samantha A Brugmann; L Henry Goodnough; Jill A Helms; Peggy J Farnham; Eran Segal; Howard Y Chang
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

3.  HOTAIR/miR-214-3p/FLOT1 axis plays an essential role in the proliferation, migration, and invasion of hepatocellular carcinoma.

Authors:  Chong Liu; Zhonghua Shang; Yu Ma; Jianfang Ma; Jian Song
Journal:  Int J Clin Exp Pathol       Date:  2019-01-01

4.  Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.

Authors:  D D Anthony; T Umbleja; J A Aberg; M Kang; K Medvik; M M Lederman; M G Peters; M J Koziel; E T Overton
Journal:  Vaccine       Date:  2011-03-11       Impact factor: 3.641

5.  STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.

Authors:  David Vasquez-Dunddel; Fan Pan; Qi Zeng; Mikhail Gorbounov; Emilia Albesiano; Juan Fu; Richard L Blosser; Ada J Tam; Tullia Bruno; Hao Zhang; Drew Pardoll; Young Kim
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 6.  Ageing and inflammation in patients with HIV infection.

Authors:  M Nasi; S De Biasi; L Gibellini; E Bianchini; S Pecorini; V Bacca; G Guaraldi; C Mussini; M Pinti; A Cossarizza
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

Review 7.  Myeloid-derived suppressor cells: linking inflammation and cancer.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Coordinated expression of ncRNAs and HOX mRNAs in the human HOXA locus.

Authors:  Yasnory T F Sasaki; Miho Sano; Taishin Kin; Kiyoshi Asai; Tetsuro Hirose
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

Review 9.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

10.  Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation.

Authors:  Xue Q D Wang; Josée Dostie
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

View more
  3 in total

1.  Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.

Authors:  Fen Zhao; Hui Tian; Xinchao Liu; Yuanxiazi Guan; Ying Zhu; Peng Ren; Jianbo Zhang; Yinjun Dong; Lei Fu
Journal:  Oxid Med Cell Longev       Date:  2022-05-19       Impact factor: 7.310

Review 2.  Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani
Journal:  Open Biol       Date:  2021-11-10       Impact factor: 6.411

3.  Effects of propofol on neuroblastoma cells via the HOTAIRM1/miR-519a-3p axis.

Authors:  Guan Wang; Yao Yu; Yang Wang
Journal:  Transl Neurosci       Date:  2022-03-10       Impact factor: 1.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.